JMP Securities began coverage on shares of U.S. Physical Therapy (NYSE:USPH – Free Report) in a research report sent to investors on Monday morning, MarketBeat Ratings reports. The firm issued an outperform rating and a $113.00 price target on the stock.
USPH has been the subject of several other research reports. JPMorgan Chase & Co. raised their target price on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the stock an “overweight” rating in a research note on Tuesday, December 3rd. Barrington Research restated an “outperform” rating and issued a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st. Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and boosted their target price for the stock from $100.00 to $115.00 in a research report on Monday. Finally, StockNews.com raised U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Wednesday, August 21st. One equities research analyst has rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, U.S. Physical Therapy presently has an average rating of “Buy” and an average target price of $114.00.
Read Our Latest Stock Report on U.S. Physical Therapy
U.S. Physical Therapy Price Performance
U.S. Physical Therapy Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Shareholders of record on Friday, November 15th were issued a $0.44 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 dividend on an annualized basis and a yield of 1.90%. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 187.23%.
Insider Transactions at U.S. Physical Therapy
In other news, Director Bernard A. Harris, Jr. sold 2,000 shares of U.S. Physical Therapy stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the transaction, the director now owns 16,726 shares of the company’s stock, valued at $1,554,681.70. The trade was a 10.68 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Nancy Ham sold 1,172 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $96.72, for a total transaction of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares in the company, valued at approximately $107,552.64. The trade was a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 7,412 shares of company stock valued at $706,605 in the last quarter. 1.70% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the business. Canada Pension Plan Investment Board purchased a new stake in U.S. Physical Therapy during the 2nd quarter worth about $28,000. Innealta Capital LLC acquired a new stake in shares of U.S. Physical Therapy during the 2nd quarter worth about $30,000. Quest Partners LLC grew its holdings in shares of U.S. Physical Therapy by 2,808.3% during the second quarter. Quest Partners LLC now owns 349 shares of the company’s stock worth $32,000 after buying an additional 337 shares in the last quarter. Quarry LP grew its holdings in shares of U.S. Physical Therapy by 1,291.9% during the second quarter. Quarry LP now owns 515 shares of the company’s stock worth $48,000 after buying an additional 478 shares in the last quarter. Finally, Ridgewood Investments LLC acquired a new position in shares of U.S. Physical Therapy in the second quarter valued at approximately $51,000.
U.S. Physical Therapy Company Profile
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
- Five stocks we like better than U.S. Physical Therapy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Trading Halts Explained
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- EV Stocks and How to Profit from Them
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.